NASDAQ NMS - GLOBAL MARKET · IMNN
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Imunon Inc

Imunon Inc

Biotechnology
$1.64
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
IMNN
Imunon Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

49/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is IMNN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading IMNN catalysts
About Imunon Inc
PHARMACEUTICAL PREPARATIONS
Listed since
1995
Employees
20
Country
US

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.64
Last session
Day high
$1.64
Last session
Day low
$1.64
Last session
Previous close
$1.64
52W high
$6.35
-74.17% from high
52W low
$1.51
3% of range
Market cap
$9.2M
EPS
$-4.6900
Beta
0.44
Shares out
5.6M
Avg volume
195.8K
VWAP
$1.64
Last session
Price history computed in-house
1W
+2.50%
1M
+8.61%
3M
-25.45%
1Y
-74.77%
YTD
-56.96%
SMA 50 $1.75 · below
SMA 200 $2.86 · below
52W position 3%

IMNN overview

Veridion Score
49
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around IMNN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading IMNN Form 4 filings
Public disclosures

Congress activity in IMNN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for IMNN in the cached public ledger.

Federal contracts

IMNN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IMNN in this window.
Lobbying spend

IMNN lobbying filings, year to date.

Registered lobbying filings matched to Imunon Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IMNN in this window.
Loading news for IMNN
Analyst ratings
Sovereign unlock shows live analyst consensus for IMNN.
Options
Sovereign unlock shows live options positioning for IMNN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.